Related Experiment Video
Updated: Sep 16, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Diagnosis and management of reactive infectious mucocutaneous eruption
Nicole Damari1, Abbie Goodman1, Catherine Bridges2
1Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Abstract:
Medicine's clinical understanding of reactive infectious mucocutaneous eruption (RIME) has evolved over time. It was previously described as Mycoplasma pneumoniae-induced rash and mucositis (MIRM), and before that as a variant of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Here, we summarize the current understanding of best practices for RIME diagnosis and management.
Insights
Reactive infectious mucocutaneous eruption (RIME) is a distinct clinical entity. This review summarizes current best practices for diagnosing and managing RIME, formerly known as Mycoplasma pneumoniae-induced rash and mucositis (MIRM).
Area of Science:
- Infectious diseases
- Dermatology
- Pediatric infectious diseases
Background:
- Reactive infectious mucocutaneous eruption (RIME) has undergone evolving clinical classification.
- Previously termed Mycoplasma pneumoniae-induced rash and mucositis (MIRM).
- Historically considered a variant of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Purpose of the Study:
- To summarize current understanding of RIME diagnosis.
- To outline best practices for RIME management.
- To clarify the distinction between RIME and other mucocutaneous disorders.
Main Methods:
- Literature review of RIME diagnosis and management.
- Synthesis of clinical guidelines and expert consensus.
- Analysis of historical and current case studies.
Main Results:
- RIME is recognized as a distinct entity separate from Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
- Key diagnostic criteria for RIME have been established.
- Evidence-based management strategies for RIME are presented.
Conclusions:
- Accurate diagnosis of RIME is crucial for appropriate management.
- Current best practices emphasize early recognition and supportive care.
- Further research is needed to fully elucidate RIME pathogenesis and optimize treatment.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

